Extracellular matrix metabolism in diabetic nephropathy.
about
Fibrosis in diabetes complications: pathogenic mechanisms and circulating and urinary markersThe effects of medicinal plants on renal function and blood pressure in diabetes mellitusThe kallikrein-kinin system in diabetic nephropathyEffective Delivery of Endogenous Antioxidants Ameliorates Diabetic NephropathyStore-operated calcium entry and diabetic complicationsIncreased hexokinase II expression in the renal glomerulus of mice in response to arsenicAS101 prevents diabetic nephropathy progression and mesangial cell dysfunction: regulation of the AKT downstream pathwayA potential role for caveolin-1 in VEGF-induced fibronectin upregulation in mesangial cells: involvement of VEGFR2 and SrcEmodin suppresses hyperglycemia-induced proliferation and fibronectin expression in mesangial cells via inhibiting cFLIPEffect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptational responseRosiglitazone prevents high glucose-induced vascular endothelial growth factor and collagen IV expression in cultured mesangial cells.Effects of astragalus injection on the TGFβ/Smad pathway in the kidney in type 2 diabetic mice.Expression of toll-like receptor 2 in glomerular endothelial cells and promotion of diabetic nephropathy by Porphyromonas gingivalis lipopolysaccharide.Proteomic profile of primary isolated rat mesangial cells in high-glucose culture condition and decreased expression of PSMA6 in renal cortex of diabetic rats.Laminin α1 regulates age-related mesangial cell proliferation and mesangial matrix accumulation through the TGF-β pathwayDiabetes-induced alterations in the extracellular matrix and their impact on myocardial function.Hyperglycemia-induced Renal P2X7 Receptor Activation Enhances Diabetes-related Injury.Altered ECM deposition by diabetic foot ulcer-derived fibroblasts implicates fibronectin in chronic wound repair.Functional characterization of the plasmacytoma variant translocation 1 gene (PVT1) in diabetic nephropathyPathobiology of renal-specific oxidoreductase/myo-inositol oxygenase in diabetic nephropathy: its implications in tubulointerstitial fibrosis.Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathyEffects of high glucose on integrin activity and fibronectin matrix assembly by mesangial cellsModulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience.Genipin inhibits mitochondrial uncoupling protein 2 expression and ameliorates podocyte injury in diabetic mice.The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potentialFrom fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy.Sulodexide decreases albuminuria and regulates matrix protein accumulation in C57BL/6 mice with streptozotocin-induced type I diabetic nephropathyRegulation of mRNA translation in renal physiology and disease.Expression of Toll-Like Receptor 4 in Glomerular Endothelial Cells under Diabetic Conditions.Activation of glycogen synthase kinase 3β ameliorates diabetes-induced kidney injury.A glimpse of matrix metalloproteinases in diabetic nephropathy.Oxidized LDL immune complexes stimulate collagen IV production in mesangial cells via Fc gamma receptors I and III.Activation of bone morphogenetic protein 4 signaling leads to glomerulosclerosis that mimics diabetic nephropathyFenofibrate attenuated glucose-induced mesangial cells proliferation and extracellular matrix synthesis via PI3K/AKT and ERK1/2.Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathyGrowth factor midkine is involved in the pathogenesis of diabetic nephropathy.Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.Erk in kidney diseases.Chaihuang-Yishen granule inhibits diabetic kidney disease in rats through blocking TGF-β/Smad3 signaling.Diffuse glomerular nodular lesions in diabetic pigs carrying a dominant-negative mutant hepatocyte nuclear factor 1-alpha, an inheritant diabetic gene in humans.
P2860
Q24644869-1B56F9AF-A9EE-4222-884A-C95745F357B2Q26822062-25CDB2F2-6F03-4F45-8043-B256AC0424E7Q26827473-3BE30B2E-ECF3-406E-8AC6-65EA99693206Q27303768-B3996CFC-229A-4213-801E-DC34F00145D8Q28085037-731750C5-2D04-4193-BBDC-0881CE930F44Q28396987-6B2950AF-9A80-4370-B773-31A8E5CA6CD1Q28542507-AC10E1C7-18CA-4237-BD81-F68E8AF6A57AQ28567391-6EBCB660-9DF5-43A5-966A-F7FE50E40AA0Q28581865-09CB9AC5-E398-4C9A-8929-D23C4ECF78CEQ28582870-0A5A051F-299C-404E-A44F-75C14F739292Q29347056-E3767CAC-C65D-41A2-AE34-590FF09FF965Q33620712-36BCE14A-5F27-4D7A-B842-95CD67427A1BQ33623473-21A2D17B-101B-4632-B421-E21648DA7E5DQ33638297-9121D32D-86CF-465D-9C6B-74170E79257FQ33708674-DFC69596-8882-4F2C-9820-288656B839CBQ33711031-39AC2A7C-8151-448D-9740-9030586FE8D7Q33715745-3EB8E76B-BEAD-4266-B025-16CD985CCE5DQ33881787-3CC74757-FC31-4E48-9132-1E9E947A8072Q33883432-C73F095F-A4F6-4D51-A9E2-6F18AD80B01EQ33917811-6FD8ABDB-6C0D-4C96-B3A7-E7E1706A7B5CQ34067504-3CCAC520-F2AA-4D61-8907-F136A5D9A614Q34081401-04D3A781-A34D-4068-8BF7-62058B0F25AEQ34212843-0549A545-F305-4DC7-B4A3-2310752DE281Q34358426-DD11BCE8-8A37-4581-BE4E-174D6D10A7D2Q34527184-EAC9BA41-7151-4E9B-AC7D-4E66B84C1BC3Q34554570-4F63CA95-E0EF-4972-B262-E67F17E80E66Q34563204-FBE009BF-F972-4342-9AFF-45FC19C3A85AQ34609025-9890CCC0-86F7-4384-929E-43026B803D02Q34647622-7279B0CD-A2F0-4192-ADB4-5C1F5BC8E97AQ34737936-719B063A-2784-4746-8FB7-E8111CD69F7EQ34796034-09F8C46D-AAAD-44DE-B7E5-7DE33F64AC60Q34988136-C1CD11AD-7BD8-48C0-B281-CD4B2BA788E5Q35011158-837567FA-1624-4102-AF8B-7004AAF0DA78Q35018587-864AF599-352A-4B90-8688-810BA6A4BDC1Q35035283-58BDA719-B954-41A1-B622-6515A055F1A3Q35070717-310060F0-AABF-4A1B-BE38-5D9D5DE935B4Q35076442-A21C09A7-E3EA-4DFC-A322-92A240DC0DACQ35101922-0CB135CD-37FD-416D-84D3-4395F474C17FQ35124896-484A85E7-D7C3-4531-BF23-3739B9F2A432Q35125191-8468B1E4-0D53-44C1-8503-80523E97E936
P2860
Extracellular matrix metabolism in diabetic nephropathy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
name
Extracellular matrix metabolism in diabetic nephropathy.
@ast
Extracellular matrix metabolism in diabetic nephropathy.
@en
Extracellular matrix metabolism in diabetic nephropathy.
@nl
type
label
Extracellular matrix metabolism in diabetic nephropathy.
@ast
Extracellular matrix metabolism in diabetic nephropathy.
@en
Extracellular matrix metabolism in diabetic nephropathy.
@nl
prefLabel
Extracellular matrix metabolism in diabetic nephropathy.
@ast
Extracellular matrix metabolism in diabetic nephropathy.
@en
Extracellular matrix metabolism in diabetic nephropathy.
@nl
P1476
Extracellular matrix metabolism in diabetic nephropathy.
@en
P2093
Nadia Abdel Wahab
Roger M Mason
P304
P356
10.1097/01.ASN.0000065640.77499.D7
P577
2003-05-01T00:00:00Z